Active Not Recruiting OBSERVATIONAL NCT04852653

A Prospective Feasibility Study Evaluating Extracellular Vesicles Obtained by Liquid Biopsy for Neoadjuvant Treatment Response Assessment in Rectal Cancer (RECC-EV)

Sponsor: University Hospital, Bordeaux

Interventions Supplementary blood samples collection during the normal follow up of the patients

Updated 7 times since 2021 Last updated: Jul 29, 2025 Started: Sep 21, 2021 Primary completion: Mar 31, 2026 Completion: Mar 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Liquid Biopsy and Rectal Cancer and is currently ongoing. University Hospital, Bordeaux leads this study, which shows 7 recorded versions since 2021 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

7 versions recorded

Aug 2025 — Present [monthly]

Active Not Recruiting

Status: Recruiting → Active Not Recruiting
Sep 2024 — Aug 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Apr 2024 — Jul 2024 [monthly]

Recruiting
Feb 2023 — Apr 2024 [monthly]

Recruiting

▶ Show 2 earlier versions

Sep 2022 — Feb 2023 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
May 2021 — Sep 2022 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Bordeaux

Data source: University Hospital, Bordeaux

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bordeaux, France